“I find the opportunity to interact with colleagues from other disciplines to be one of the most rewarding aspects of working in plasma medicine, and I am very excited to have even more of these interactions in the next ten years”, says Professor Andrew Gibson.
© Damian Gorczany

Plasma Medicine Achieving success together

Andrew Gibson from the Research Group for Biomedical Plasma Technology explains, what will be crucial to translate emerging approaches such as plasma-based cancer therapy, into clinical practice.

One of the most interesting and important features of plasma medicine as a topic is its interdisciplinary nature, bringing together natural scientists, engineers and clinicians. The number of different scientific areas represented within the field has been continuously growing in the past ten years. This interdisciplinary environment has been a driving force behind clinical studies in a number of cases, wound treatment being a prominent example.

Over the next ten years, as plasma medicine continues to grow and attract new researchers, I expect this trend to accelerate and for the field to become even more interdisciplinary than it is today. This will bring new perspectives on existing questions, new therapeutic concepts, and novel research methods. I believe that these factors will be crucial for new scientific discoveries and the translation of emerging approaches such as plasma-based cancer therapy, into clinical practice.

Document download

Published

Tuesday
13 July 2021
10:23 am

By

Julia Weiler (jwe)

Translated by

Donata Zuber

Share